We welcome the comments, and appreciate the interest in our work by Kruger et al., 1 and we thank the Editor for the opportunity to respond to their observations. Their data and comments contain some interesting data but also some generally misleading viewpoints. In our report, we specifically highlighted the critical impact that polymorphism in the c-kit gene can exert on the clinical phenotype. The single nucleotide change (ATG-CTG) in codon 541 is an example of a clearly single nucleotide polymorphism (SNP) of M541L, as described in our earlier report. 2 SNPs were detected in five of the six chronic myelogenous leukemia (CML) patients as shown in Table 2 in that earlier report. 2 This was because the DNA of the skin and hair root had the same variation. The same variation was found only in bone marrow cells of blastic crisis (BC) in the case of the remaining one patient (Case No. 2). This means that M541L could not be the cause of chronic-phase CML. N564K was also found only in the bone marrow cells of BC of that patient (Case No. 1). This means that N564K also could not be the cause of the chronic phase of CML.
Kruger et al. also showed conservation of the amino acid in codons 559, 642 and 820, which are those found to undergo mutation, between mammal and fish. On the other hand, a difference in the conservation of the amino acid in codon 541 was shown between mammals and fish. Kruger et al. state that the difference in amino acid in codon 541 between mammals and fish means that M541L is one of the reasons for polymorphism and not a mutation. We agree with their opinion. Many investigators have searched for mutations of the c-kit gene. Nobody other than Murakami et al. 3 has proposed that M541L has the possibility of SNPs or mutation. M541L has the potential for functional SNPs, since we confirmed that c-kit cDNA with M541L induced a different response of Ba/F3 cells to stem cell factor.
Kruger et al. also show that the genotype frequencies for sequence variations were 8.1-8.3%. No difference was observed in the frequency of SNPs between CML patients and the healthy control group in Caucasians. The frequency of M541L in our healthy control group is lower than that in the Caucasian group in the Kruger et al. report. We would like to emphasize that ethnic differences in SNPs of many genes are well known and common. 4, 5 We surmise that the conservation of the aminoacid residues in codon 541 in mammals means that they are important amino-acid residues. This points to the possibility of these important amino-acid residues having some critical function in mammals. We would like to know the degree of conservation of novel CNPs in codon 546 between species. We doubt that there are amino-acid differences in codon 546 in mammals.
The analysis based on sorting intolerant from tolerant aminoacid substitutions (SIFT) also yielded intriguing data. As we reported, M541L is an SNP. It is thus reasonable that M541L is tolerant. The important thing is that M541L may result in expression of some kind of function in vitro in Ba/F3 cells and Japanese CML patients.
We would like to know the clinical and hematological data of Kruger et al.'s 16 Caucasian CML patients and 26 healthy controls having M541L. Specifically, what we would like to know is the difference in the clinical and hematological data of the 16 Caucasian CML patients and the 26 healthy controls. Many polymorphisms result in changes in enzymatic activities. 6 The M541L SNP and N564K variation may result in subtle changes in the function of the c-kit molecule both in vitro and in Japanese CML patients. 2 These subtle changes in the function of the c-kit molecule are not the causes of CML, but they may be the causes of the different hematological and clinical phenotypes in some CML patients.
Early elucidation of whether or not M541L is associated with CML in Caucasians is welcome. However, function analysis using some other in vitro systems will be needed in order to decide whether or not there is an association between the hematological phenotype of CML and SNPs. In summary, we believe that the limited data presented by Kruger et 
